Intraocular pressure variations after neodymium: YAG iridotomy using topical 2% dorzolamide
Tóm tắt
A double-masked study randomly assigned 60 eyes of 60 patients undergoing neodymium: YAG (Nd:YAG) laser iridotomy to pretreatment with either placebo (group 1) or 2% dorzolamide eyedrops in a single dose (group 2). Intraocular pressure (IOP) was measured 30 minutes and 1, 2, 3, 4, 6, and 24 hours after iridotomy. Group 2 pressures were lower and returned to normal levels faster than in group 1. Thus, dorzolamide used preoperatively may safeguard IOP.
Tài liệu tham khảo
Pollack IP, Robin AL, Dragon DM, et al. Use of the neodymium: YAG laser to create iridotomies in monkeys and humans. Trans Am Ophthalmol Soc 1984;82:307–328.
Klapper RL. Q-switched neodymium YAG laser iridotomy. Ophthalmology. 1984;91:1017–1021.
McAllister JA, Schwartz W, Moster MR, Spaeth GL. Laser peripheral iridotomy comparing Q-switched neodymium YAG with argon. Trans Ophthalmol Soc UK. 1984;104:67–69.
Moster MR, Schwartz LW, Spaeth GL, Wilson RP, McAllister JA, Poryzees EM. Laser iridotomy: a controlled study comparing argon and neodymium: YAG. Ophthalmology. 1986;93:20–24.
Schwartz LW, Moster MR, Spaeth GL, Wilson RP, Poryzees E. Neodymium YAG laser iridectomies in glaucoma associated with closed or occludable angles. Am J Ophthalmol. 1986;102:41–44.
Drake MV. Neodymium: YAG laser iridotomy. Surv Ophthalmol. 1987;32:171–177.
Frankhauser F, Roussel P, Steffen J, Van der Zypen E, Chrenkova A. Clinical studies on the efficiency of high power laser radiation upon some structures of the anterior segment of the eye. Int Ophthalmol. 1981;3:129–139.
Terry AC, Stark WJ, Maumenee AE, Fagadau W. Neodymium-YAG laser for posterior capsulotomy. Am J Ophthalmol. 1983;96:716–720.
Channel MM, Beckman H. Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol. 1984;102:1024–1026.
Schubert HD. A history of intraocular pressure rise with reference to the Nd:YAG laser. Surv Ophthalmol. 1985;30:168–172.
Migliori ME, Beckman H, Channell MM. Intraocular pressure changes after neodymium-YAG laser capsulotomy in eyes pretreated with timolol. Arch Ophthalmol. 1987;105:473–475.
Pollack IP, Brown RH, Crandall AS, Robin AL, Stewart RH, White GL. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol. 1988;106:754–757.
Schrems W, Eichelbronner O, Kreigelstein GK. The immediate IOP response of Nd:YAG laser iridotomy and its prophylactic treatability. Acta Ophthalmol. 1984;620:673–680.
Schrems W, van Drop HP, Wendel M, Krieglstein GK. The effect of YAG laser iridotomy on the blood aqueous barrier in the rabbit. Graefes Arch Clin Exp Ophthalmol. 1984;221:179–181.
Henry JC, Krupin T, Schultz J, Wax M. Increased intraocular pressure following neodymium-YAG laser iridectomy. Arch Ophthalmol. 1986;104:178.
Khodadoust AA, Arkfeld DF, Caprioli J, Sears ML. Ocular effect of neodymium-YAG laser. Am J Ophthalmol. 1984;98:144–152.
Liesegang TJ, Bourne WM, Ilstrup DM. Secondary surgical and neodymium-YAG laser discissions. Am J Ophthalmol. 1985;100:510–519.
Richter CU, Arzeno G, Pappas HR, Steinert RF, Puliafito C, Epstein DL. Intraocular pressure elevation following Nd:YAG laser posterior capsulotomy. Ophthalmology. 1985;92:636–640.
Richter CU, Arzeno G, Pappas HR, Arrigg CA, Wasson P, Steinert RF. Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol. 1985;103:912–915.
Pham Dup T, Wollensak J, Becker U. Intraokulare Drucksteigerung nach Nd-YAG laser Kapsulotomie: Pathogenese und prophylaktische Therapie. Klin Monatsbl Augenheilkd. 1987;191:270–274.
Wetzel W. Ocular aqueous humor dynamics after photodisruptive laser surgery procedures. Ophthalmic Surg. 1994;25:298–302.
Stark WJ, Worthen D, Holladay JT, Murray G. Neodymium: YAG lasers: an FDA report. Ophthalmology. 1985;92:209–212.
Robin AL. Intraocular pressure elevation following anterior segment laser surgery. Ophthalmic Laser Ther. 1986;1:101–106.
Lippa EA, Von Denffer HA, Hofmann HM, Brunner-Ferber FL. Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1988;106:1694–1696.
Hennekes R, Pfeiffer N, Lippa EA, Garus H, Grehn F, Jaeger A. MK-927: an active topical carbonic anhydrase inhibitor in patients. Invest Ophthalmol Vis Sci. 1988;29(suppl):82.
Bron AM, Lippa EA, Hofmann HM, et al. MK-927: a topically effective carbonic anhydrase inhibitor in patients. Arch Ophthalmol. 1989;107:1143–1146.
Higginbotham EJ, Kass MA, Lippa EA, Batenhorst RL, Panebianco DL, Wilensky JT. MK-927: a topical carbonic anhydrase inhibitor: dose response and duration of action. Arch Ophthalmol. 1990;108:65–68.
Lynch MG, Quigley HA, Green WR, Pollack IP, Robin AL. The effect of neodymium: YAG laser capsulotomy on aqueous humor dynamics in the monkey eye. Ophthalmology. 1986;93:1270–1275.
Mainster M, Sliney D, Belcher CD III, Buzney SM. Laser photodisruptors. Ophthalmology. 1983;90:973–991.
Robin AL, Pollack IP, Quigley HA, D'Annas, Addicks EM Histologic studies of angles structures after laser iridotomy in primates. Arch Ophthalmol. 1982;100:1665–1670.
Dragon DM, Robin AL, Pollack IP, D'Anna S, Addicks EM. Neodymium: YAG laser iridotomy in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1985;26:789–796.
Maren TH, Bar-Ilan A. Ocular pharmacology and hypotensive activity of a topically active carbonic anhydrase (CA) inhibitor, a 4-alkylaminothienothiopyran-2-sulfonamide, MK-927. Invest Ophthalmol Vis Sci. 1988;29(suppl):16.
Sugrue MF, Gautheron P, Grove J, et al. MK-927: A topically effective ocular hypotensive carbonic anhydrase (CA) inhibitor in rabbits. Invest Ophthalmol Vis Sci. 1988;29:(suppl):81.